Yann Mazabraud, EVP, Head of International at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 35,500 shares at $60.37 ($2.2M) on 2025-04-08, disclosed to the SEC on 2025-04-10.
Scheduled sale ($2.2M) by EVP, Head of International under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.37 | 8,438 | $509K | 23.5% |
| 2 | $60.37 | 8,438 | $509K | 23.5% |
| 3 | $61.54 | 9,312 | $573K | 26.5% |
| 4 | $61.54 | 9,312 | $573K | 26.5% |
| Total | $60.98 avg | 35,500 | $2.2M | 100% |
| Filing → |
| RYTM | SELL | 2025-03-18 | $7.7M | — | Filing → |
| RYTM | SELL | 2024-03-19 | $628K | — | Filing → |
| RYTM | SELL | 2024-02-13 | $211K | — | Filing → |